Showing 21 - 30 of 426
This paper studies the valuation of companies going public and defines a methodology to infer the growth expectations implicit in their IPO prices. The proposed reverse-engineered DCF model is operable by individual investors, as it does not require access to private information or sell-side...
Persistent link: https://www.econbiz.de/10012717296
Persistent link: https://www.econbiz.de/10012268251
Persistent link: https://www.econbiz.de/10011814028
Persistent link: https://www.econbiz.de/10011814122
Purpose -The purpose of this paper is to contribute to the literature on the valuation of initial public offerings (IPOs). In particular, it tests the presence of over-optimism when pricing IPOs on the Italian Nuovo Mercato. Design/methodology/approach -The paper investigates whether the...
Persistent link: https://www.econbiz.de/10010752652
This paper investigates the valuation and merger and acquisition (M&A) dynamics of the population of 254 biotech firms that went public in Europe between 1990 and 2009. Among these, we identify a high proportion (40%) of firms affiliated with a university or another public research organization....
Persistent link: https://www.econbiz.de/10010865448
Persistent link: https://www.econbiz.de/10009956423
Persistent link: https://www.econbiz.de/10009974271
Persistent link: https://www.econbiz.de/10010069952
Persistent link: https://www.econbiz.de/10009895610